US Arginine Prices Increase 0.33% as Late-Month Buying Provides Modest Support

Arginine prices in the USA moved higher toward the end of August 2026, rising 0.33% in the final week of the month as trading remained range-bound. Early August showed incremental upward pressure, followed by mid-month stability and a modest late-month recovery. Routine procurement and normal operating rates supported Arginine offers, although the broader 12-week bearish trend continued to weigh on sentiment. Weekly assessment data indicated short-term support in the CFR Los Angeles corridor.

Demand conditions provided moderate support to the Arginine market during August. Detailed end-use segmentation across pharmaceutical, nutraceutical, and feed applications was not available from the source reporting. Nevertheless, routine procurement and typical buying patterns helped prevent deeper price declines. ChemAnalyst data recorded a 0.83% weekly increase for the week ending August 21, indicating renewed short-term buying interest. Despite this improvement, the persistent bearish trend suggests that underlying Arginine demand momentum remains mixed.

On the supply side, Arginine availability remained stable as producers maintained normal operating rates. China’s private manufacturing PMI rose to 51.5 in August from 50.9 in July, with output recording its fastest growth in three months. New orders and export business also improved, while manufacturers increased purchasing activity after reducing it in July. Feedstock and upstream cost information was not provided, preventing a direct assessment of raw-material and energy-cost movements on producer margins. Consequently, Arginine pricing reflected balanced availability and routine procurement rather than significant supply tightness.

Weekly movements showed a changing Arginine price pattern. Prices increased during the first week of July before remaining broadly stable through much of July and early August. The market experienced a brief dip in early August and subsequently recovered, with gains of roughly 0.8% followed by the 0.33% increase in the closing week. This sequence indicates that Arginine is moving within a relatively narrow band, with intermittent buying interest lifting bids while the longer bearish backdrop keeps market participants cautious.

Looking ahead, the Arginine outlook remains cautiously balanced. Continued normal production and steady procurement could sustain the support observed in late August. However, the lingering bearish trend may restrict significant upside unless clearer demand signals emerge. In the absence of major feedstock changes, supply disruptions, or stronger end-use consumption, Arginine prices are expected to remain range-bound into early autumn. Any sharper movement will likely depend on unexpected supply developments or a material pickup in commercial buying. Overall, Arginine market conditions point toward limited near-term volatility, according to ChemAnalyst analysis.